Bone growth stimulator boosts OrthoLogic
This article was originally published in Clinica
Executive Summary
OrthoLogic reported sales of $4.9 million in 1994, boosted by US sales of more than $3 million for the OrthoLogic 1000 bone growth stimulator which was approved by the FDA in March last year. By the end of 1994, the US company estimated that it held about 10% of the $480 million annual market for bone growth stimulators.